Product Code: RP-ID-10013465 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10013465
Market Overview:
Global Drug Screening Market Size Study, by Product & Service (Drug Screening Product, Drug Screen Services) by Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples) by End-Use (Workplace, Drug Treatment Centre, Pain Management Centre, School & College, Hospitals, Individual Users, Drug Testing Laboratories, CJSALEA ) by Regional Forecasts 2017-2025
Global Drug Screening Market valued approximately USD 4.9 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2017-2025. Driven by increasing consumption of drug & alcohol, stringent regulations mandating drug and alcohol testing the global drug increasing market is witnessing various opportunities over the forecast period. Furthermore, government funding, and novel product development are anticipated to compel positive growth in the market.
The global drug screening market is segmented by product & services, sample type and end-use. On the basis of end-user segment, the market is segmented into workplaces, criminal justice systems and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. Currently, the market is dominated by workplace drug testing segment. Increasing awareness among organizations for regular drug testing and rising safety concerns at both corporate and industrial work place are primarily driving the growth of this segment. Schools and colleges end-user segment is anticipated to grow at a significant rate over the forecast period.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
 Drug Screening Product
o Analytical Instruments
o Rapid Testing Devices
 Drug Screen Services
By Sample Type:
 Urine Samples
 Breath Samples
 Oral Fluid Samples
 Hair Samples
 Other Samples
By End-Use:
 Workplace
 Criminals Justice Systems & Law Enforcement Agencies (CJSALEA)
 Drug Treatments Centre
 Pain Management Centre
 Schools & Colleges
 Hospitals
 Individual Users
 Drug Testing Laboratories
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market Alere, Thermo Fisher Scientific
Dragewerk , Labcorp, Quest Diagonstics, Alfa Scientific Desings, Lifeloc, MPD Inc., Orasure
Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, Siemens Healthineers Frequent cross industry partnerships are leading to market consolidation.
Target Audience of the Global Drug Screening Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Dragewerk
Labcorp
Lifeloc
MPD Inc.
Omega Laboratories
Orasure
Premier Biotech
Psychemedics
Quest Diagonstics
Roche
Shimadzu
Siemens Healthineers
Thermo Fisher Scientific
Related Reports
Proof of Quality & Reliability
